Skip to main content

Table 1 Patient participant characteristics

From: Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

Patient code Gender Age group (years) Treatment-taking profile at time of interview Treatment history
P01 Female 20–29 Partially adherent New pt (no prior tx history)
P02 & P02 FU Female 20–29 LFT Extensive (DS to DR)
P03 & P03 FU Female 20–29 Partially adherent Extensive (DS to DR)
P04 Male 20–29 Adherent New pt (no prior tx history)
P05 Male 40–49 Adherent Tx after LFT from SCR
P06 Male 20–29 Partially adherent Previous incomplete DS tx
P07 Female 20–29 LFT Previous incomplete DS tx
P08 Male 50–59 Partially adherent Previous incomplete DS tx
P09 Female 20–29 Partially adherent Previous incomplete DS tx
P10 Male 20–29 Adherent New pt (no prior tx history)
P11 Female 20–29 Adherent Relapse
P12 Female 60–69 Adherent New pt (no prior tx history)
P13 Female 20–29 Adherent New pt (no prior tx history)
P14 Female 20–29 Partially adherent Relapse
P15 Male 30–39 Adherent New pt (no prior tx history)
P16 Male 20–29 Partially adherent New pt (no prior tx history)
P17 Male 40–49 Adherent Extensive (DS to DR)
P18 & P18 FU Female 20–29 Adherent Extensive (DS to DR)
P19 Male 16–20 Partially adherent New pt (no prior tx history)
P20 Male 20–29 Adherent Relapse
P21 Male 20–29 Adherent Relapse
P22 Male 20–29 Adherent New pt (no prior tx history)
P23 & P23 FU Male 16–20 Adherent New pt (no prior tx history)
P24 Female 30–39 LFT 1 previous course (failure after amplification)
P25 Female 20–29 LFT New pt (no prior tx history)
P26 Female 60–69 LFT 1 previous course (failure after amplification)
P27 Female 60–69 LFT 1 previous course
P28 Male 20–29 Partially adherent Relapse
P29 Male 30–39 LFT Relapse
P30 Female 30–39 Partially adherent Unknown
P31 Female 20–29 Partially adherent Unknown
P32 Male 30–39 LFT 2 previous courses
P33 Female 30–39 Partially adherent New pt (no prior tx history)
P34 Female 30–39 Adherent 1 previous course
P35 Female 30–39 Adherent 2 previous courses
  1. FU follow-up interview, Tx treatment, Pt patient, LFT lost from treatment, DS drug sensitive, DR drug resistant, SCR short-course regimen (9 month MDR-TB treatment regimen being piloted)